Concepedia

Halla Nimeiri

HN

47

Publications

3.1K

Citations

28

H-Index

2008

Active since

Affiliations

Northwestern University(Current)

Dana-Farber Cancer Institute

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

The Ohio State University

The University of Texas MD Anderson Cancer Center

Halla Nimeiri is an author at Northwestern University specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2008–2024

47

Publications

47

Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study

Van K. Morris, Mohamed E. Salem, Halla Nimeiri et al. · The Lancet Oncology · 2017 · 383 citations

, , +4

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

Pamela L. Kunz, Noah Graham, Paul J. Catalano et al. · Journal of Clinical Oncology · 2022 · 268 citations · Full text

Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study

Suneel D. Kamath, Aparna Kalyan, Sheetal Kircher et al. · The Oncologist · 2019 · 190 citations · Full text

Effect of High-Dose vs Standard-Dose Vitamin D<sub>3</sub> Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer

Kimmie Ng, Halla Nimeiri, Nadine J. McCleary et al. · JAMA · 2019 · 172 citations · Full text

, , +12

A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211).

Pamela L. Kunz, Paul J. Catalano, Halla Nimeiri et al. · Journal of Clinical Oncology · 2018 · 169 citations

, , +17

Rows per page

1–5 of 47